Articles tagged with Antibiotics
Plectasin disrupts the forming of the cell wall in bacteria, preventing division and ultimately leading to bacterial death. Despite its potential, the authors caution that no permanent solution exists to antibiotic resistance.
A study published in JAMA found that patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease (COPD) who received antibiotics within the first 2 hospital days had improved outcomes, including lower likelihood of mechanical ventilation and fewer readmissions. Antibiotics also reduced hospital costs.
A study published in the Journal of Experimental Medicine suggests that boosting interleukin-10 levels can protect against lethal E. coli K1 infection without antibiotic side effects. Researchers seek to determine its safety and efficacy in human infants infected with the bacterium.
A fully automated minilab developed by Munich researchers can quickly identify antibiotic residues in milk, providing a fast and simple solution to the current laborious and expensive testing method. The system takes just under six minutes to produce a result, reducing production losses and disposal costs for the dairy industry.
Researchers have created a two-in-one formula combining an antibiotic and anti-inflammatory drug, delivered via nano-sized particles that extend medication duration. This development holds promise for easier treatment of bacterial keratitis, potentially reducing hospitalization rates.
Children and adolescents with cystic fibrosis who received azithromycin did not experience improved lung function compared to those receiving placebo. However, they showed a significant reduction in pulmonary exacerbations and weight gain.
Researchers highlight underdiagnosis of pediatric hepatitis C, increased risk of inflammatory bowel disease from antibiotic use in infancy. Gastroenterologists must consider unique health needs of women and children when prescribing medication.
Researchers confirm rifaximin antibiotic provides long-lasting relief of IBS symptoms, including bloating and abdominal pain. The study suggests targeted antibiotics can effectively treat IBS by altering gut bacteria.
A multicenter NIH trial led by the University of South Florida found combination antibiotics to be effective in treating Chlamydia-induced reactive arthritis. The study showed significant improvement in patients treated with combination antibiotics, with 22% experiencing complete remission and no adverse side effects.
Researchers found a combination of antibiotics to be an effective treatment for Chlamydia-induced reactive arthritis, with significant improvements seen in patients receiving a 6-month course of combination antibiotics. The results suggest potential for eradication of the persistent infection and improvement in clinical sequelae.
Researchers have discovered a new avenue to overcome tuberculosis drug resistance by targeting an enzyme that breaks down beta-lactam antibiotics. Clavulanate and meropenem combination shows promise in sterilizing TB bacteria, including XDR-strains.
A physics strategy called resonant activation is being tested as a solution for antibiotic resistance, targeting dormant persister cells. The approach involves repetitive antibiotic treatment to accelerate sterilization of bacterial colonies.
Bacteria recognize and develop resistance to vancomycin through a specific sensing mechanism. The discovery provides new understanding of the molecular basis of vancomycin resistance and represents an essential first step in developing new antibiotics that can evade bacterial sensing mechanisms.
A chemical compound, when combined with antibiotics, effectively destroys biofilms produced by antibiotic-resistant bacteria. The compound also re-sensitizes resistant bacteria to antibiotics, making it a promising treatment for difficult-to-treat infections.
Researchers found that thyme essential oil can almost completely eliminate bacteria within 60 minutes, with high efficacy against Staphylococcus species. The study suggests that essential oils could be a cheap and effective alternative to antibiotics, reducing the risk of new strains of antibiotic-resistant micro-organisms.
Researchers analyzed 52,153 Twitter tweets mentioning antibiotics and found that misinformation can travel rapidly through the network. The study highlights the importance of promoting healthy behaviors and disseminating trustworthy information on social media platforms.
The emergence of multidrug-resistant gonococcal bacteria threatens to make gonorrhoea extremely difficult to treat. Current treatment antibiotics may soon lose effectiveness due to rapid resistance development.
Researchers have identified a molecule that blocks a key signaling pathway in pathogenic gut bacteria, reducing toxin production and preventing infection. This breakthrough discovery represents a novel class of antimicrobial agents with broad-spectrum efficacy.
A 15-year French hospital program using surveillance, precautions, training, and feedback led to a 35% decrease in methicillin-resistant Staphylococcus aureus (MRSA) burden. The program was most effective in intensive care units, with a 59% decline in MRSA cases.
The Infectious Diseases Society of America calls for the development of 10 new antibiotics by 2020 due to rising antibiotic-resistant bacterial infections. The urgency is underscored by heartbreaking patient stories of those who have suffered and died from these infections.
University of Alabama scientists find that ampicillin enhances the normal function of torsinA protein in cells affected by dystonia and Parkinson's disease. The drug restored normal movement to mice and improved cellular protection against stress, leading to potential new treatments for these debilitating conditions.
Researchers found that oxytetracycline breaks down more quickly in cattle manure than in soil, due to its higher organic material and moisture content. Temperature and moisture levels also play a crucial role in degradation rates.
Beewolves have evolved a symbiotic relationship with bacteria of the genus Streptomyces that produce nine different antibiotics, providing effective protection against various pathogens. This natural defense mechanism, known as combination prophylaxis, has been used by beewolves for millions of years to safeguard their offspring.
A national poll found that most Americans would follow public health recommendations to obtain prophylactic antibiotics in response to a hypothetical anthrax attack. However, a significant minority would delay taking the recommended medication, which could put them at greater risk of serious illness.
Research by scientists at the University of Missouri Center for Agroforestry suggests that buffer strips can trap and break down veterinary antibiotics in manure fertilizers. The finding aims to mitigate concerns about the use of veterinary antibiotics in livestock farming, which may lead to drug-resistant bacteria and ecosystem harm.
Researchers found that sub-lethal doses of antibiotics trigger DNA mutations, producing germs resistant to multiple drugs. The study highlights the dangers of incomplete antibiotic treatment and calls for stricter regulations on its use.
Researchers found that two Lactobacillus strains improved Helicobacter pylori-infected gastritis by exhibiting anti-bacterial and anti-inflammatory effects. The study suggests using probiotics as an alternative to antibiotics for treating H. pylori-associated diseases.
A recent study led by Dr. Lucas Hoffman found that Pseudomonas aeruginosa, a common pathogen in cystic fibrosis lung infections, can resist powerful antibiotics due to adapting to the clogged airways. The mutation enables the bacteria to thrive in viscous lung secretions and survive oxidative stress caused by antibiotic treatment.
Researchers at North Carolina State University developed a smart coating to improve bond between implants and bone, reducing rejection and infection risks. The coating promotes bone growth and releases antimicrobial silver particles to prevent infections.
Researchers found that two antimicrobial regimens were effective in treating early, limited buruli ulcer disease, with 96% of patients healing after 8 weeks and 91% after 4 weeks. No significant surgical complications occurred.
Researchers discovered that a commonly used antibiotic, kanamycin, protects mouse ears from noise-induced hearing loss when given in low doses. The finding has significant implications for the development of new treatments and could benefit groups such as premature babies, soldiers, and airline workers.
Researchers found that lankacidin and lankamycin, two antibiotics produced by streptomyces, are more effective when used together against MRSA and other pathogens. The combination prevents protein assembly and inhibits bacterial growth, offering a new strategy for fighting antibiotic-resistant infections.
A new study found that using procalcitonin levels to prescribe antibiotics in intensive care units can reduce antibiotic exposure while maintaining patient safety. The study showed a significant reduction in antibiotic-free days among patients treated with procalcitonin.
McGill researcher discovers a link between contaminated chicken and E. coli bacteria causing urinary tract infections in young women. The study highlights the need for better food safety measures and antibiotic use regulations in agriculture.
The Lancet article advocates for tailoring antibiotic dosing to individual patients' physical characteristics, particularly for those with large body sizes. This approach could improve treatment effectiveness and safety, especially considering the increasing prevalence of obesity-related infections.
A sudden increase in antibiotic-resistant E. coli strains is spreading globally, posing a significant threat to public health. Researchers warn that the misuse of powerful antibiotics may lead to the development of even more resistant strains, rendering current treatments ineffective.
Using disinfectants can promote the growth of antibiotic-resistant bacteria, such as Pseudomonas aeruginosa. This adaptation enables the bacteria to survive and infect patients even without exposure to antibiotics.
A new study identifies two antibiotics, linezolid and moxifloxacin, as effective against the virulent community-associated MRSA strain. Meanwhile, clindamycin and doxycycline are found to induce rapid resistance development in this new strain.
A new study suggests that medical liability concerns may be driving doctors to overprescribe antibiotics in healthcare settings. The research found a strong correlation between antibiotic use and attorney density in European countries, but no such link with physician density.
Researchers at MIT and Boston University have identified a novel mechanism by which the drug hydroxyurea kills bacteria, inducing the production of toxic molecules that ultimately lead to cell death. This discovery raises the possibility of developing new antibiotics that target similar mechanisms.
A global drive is necessary to develop new antibiotics, with only a single new antibacterial approved in the USA since 2006. The EU report also shows limited progress, with just five new drugs reaching phase 3 clinical trials within the next 10 years.
Researchers have discovered a novel way to target bacterial DNA gyrase, an essential enzyme for bacterial survival and growth. The new antibiotic molecule, simocyclinone D8 (SD8), uses two heads to bind to the enzyme, making it 100 times more potent than single-headed versions.
Complicated skin and soft tissue infections (cSSTIs) require prompt treatment to prevent tissue destruction and minimize mortality. The new guidelines emphasize the importance of rapid diagnosis and initiation of antibiotic therapy, including surgical debridement for necrotizing infections.
An international study found that 51% of ICU patients were infected, with lung infections accounting for 64%, and infection rates varied by region and healthcare expenditure
A recent study conducted in Southern Malawi found that azithromycin antibiotic had no significant impact on reducing the risk of preterm labour. The research suggests that infection may not be the primary cause of preterm birth and highlights the need for further investigation into other factors contributing to this issue.
Researchers are gaining insights into how Gram-negative bacteria infect host cells and spread antibiotic resistance. The crystal structure of the outer membrane part of type IV secretion systems has been revealed, offering potential targets for novel antibiotics.
A Tel Aviv University-developed dressing can eradicate infection-causing bacteria after just two days, protecting wounds until they heal. The biodegradable, antibiotic-infused material mimics skin's protective properties and helps doctors administer high doses of antibiotics locally, reducing toxicity issues.
New studies reveal the high costs of implementing performance-reporting requirements for primary care practices, which can range from $1,000 to $11,100 per practitioner. Researchers also warn that undisclosed changes made to clinical trial outcomes threaten the integrity of scientific research. In contrast, early abortion care in famil...
A new imaging technique developed by a team of researchers could lead to the discovery of new antibiotics, antifungal, antiviral, and anti-cancer drugs. The method uses mass spectrometry to analyze chemical communication between microorganisms.
A study in Italy found that pediatricians over-prescribe antibiotics due to perceived parental expectations, particularly if parents expect a prescription for respiratory tract infections. The main factors associated with actual practices were discharge from the child's ear and parental expectation of a prescription.
A Phase II clinical study found that a vaccine candidate can cause a modest but sustained reduction in genital and gastrointestinal GBS bacterial colonization. The vaccine was also found to be safe and well-tolerated, eliciting a strong immune response.
Tufts Clinical and Translational Science Institute (CTSI) has received four NIH supplemental grant awards, totaling $1.73 million, to expand its community engagement program, improve BPD predictors, search for Lyme disease persistence, and develop a pilot project mechanism.
A Mayo Clinic study found that Clostridium difficile infections are rising in outpatient settings, with a higher proportion of cases in younger populations. The study suggests that antibiotic use may be contributing to the increased incidence and severity of C. difficile infections.
A new study suggests that a shorter course of antibiotics following tonsillectomy may be just as effective in reducing pain and promoting recovery. The research found no significant differences between children who received a 3-day versus 7-day course of postoperative antibiotics.
A Tel Aviv University drug based on an older generation antibiotic shows promise in treating colon cancer by suppressing polyp growth and repairing genes. Preclinical studies have shown a 80% reduction in polyp size and a 30% increase in mouse lifespan.
Researchers found promising results for rapid viral diagnosis tests, reducing use of antibiotics and other blood tests in children with respiratory symptoms. Larger trials are needed to confirm the finding and evaluate cost-effectiveness.
Researchers at McMaster University have identified a novel chemical compound that targets drug-resistant bacteria, offering a promising solution to combat resistant infections. The discovery provides a new approach to tackle antibiotic resistance by blocking a specific step in the development of bacterial cell surfaces.
Researchers found that universal health insurance reduces income inequities in healthcare access, but education-related disparities persist. Insured children with uninsured parents are more likely to experience unmet healthcare needs and lack preventive services.
Researchers at NYU Langone Health have found a mechanism that makes human pathogens like MRSA and anthrax resistant to numerous antibiotics. By eliminating the oxidative stress caused by many antibiotics, NO can be neutralized, rendering existing antibiotics more potent at lower doses.
Pediatric researchers at Children's Hospital of Philadelphia will investigate the most beneficial method of using antibiotics to treat urinary tract infections (UTIs) in children. The goal is to determine if a shorter treatment period can reduce drug resistance while effectively treating UTIs.